Abstract
The development of efficient recombinant protein production processes can be a critical factor in whether or not a pharmaceutical therapeutic protein can enter human clinical trials and ultimately the marketplace. This is especially true for therapeutic proteins that need to be administered on a daily basis for prolonged periods or if dosage requirements are very high. The use of Pichia pastoris as a recombinant expression host strain can be an excellent choice for such situations. P. pastoris has the potential for high expression levels (1,2), efficient secretion, and proper protein folding (3–5), and is a robust fermentation organism capable of high cell density on inexpensive simple basal salts medium (6). The development of an insulin-like growth factor I (IGF-I) production process in which P. pastoris is used as the recombinant host strain is discussed in this chapter.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Cregg, J. M., Vedvick, T. S., and Raschke, W. C. (1993) Recent advances in the expression of foreign genes in Pichia pastoris. Bio/Technology 11, 905–909.
Clare, J. J., Rayment, F. B., Ballantine, S. P., Sreekrishna, K., and Ramanos, M. A. (1991) High-level expression tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Bio/Technology 9, 455–460.
Tschopp, J. F., Sverlow, G., Kosson, R., Craig, W., and Grinna, L. (1987) High-level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris. Bio/Technology 5, 1305–1308.
Digan, M. E., Lair S. V., Brierley, R. A., Siegel, R. S., Williams, M. E., Ellis, S. B., Kellaris, P. A., Provow, S. A., Craig, W. S., Velicelebi, G., Harpold, M. M., and Thill, G. P. (1989) Continuous production of a novel lysozyme via secretion from the yeast, Pichia pastoris. Bio/Technology 7, 160–164.
Vedvick, T., Buckholz, R. G., Engel, M., Urcan, M., Kinney, J., Provow, S., Siegel, R. S., and Thill, G. P. (1991) High level secretion of biologically active aprotinin from the yeast, Pichia pastoris. J. Ind. Microbiol. 7, 197–202.
Brierley, R. A., Bussineau, C., Kosson, R., Melton, A., and Siegel, R. S. (1990) Fermentation development of recombinant Pichia pastoris expressing the heterologous gene: bovine lysozyme. Ann. NY Acad. Sci. 589, 350–362.
Preece, M. A. (1983) The somatomedins, in Hormones in Blood (Gray, C. H. and James, V. H. T., eds.) Academic, London, pp. 87–108.
Lynch, S. E., Nixon, J. C., Colvin, R. B., and Antoniades, H. N. (1987) Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc. Natl. Acad. Sci. USA 84, 7696–7700.
Burleigh, B. D. and Meng, H. (1986) Development of biosynthetic somatomedin-C/IGF-I as a product for cell culture. Am. Biotechnol. Lab. 4, 48–53.
Quin, J. D. (1992) The insulin-like growth factors. Q. J. Med. 82, 81–90.
Cotterill, A. M. (1992) The therapeutic potential of recombinant human insulinlike growth factor-I. Clin. Endocrinol. Oxford 37, 11–15.
Lewis M. E., Neff, N. T., Contreras, P. C., Stong, D. B., Oppenheim, R. W., Grebow, P. E., and Vaught, J. L. (1993) Insulin-like growth factor-I: potential for treatment of motor neuronal disorders. Exp. Neurol. 124, 73–88.
Gluckman, P., Klempt, N., Guan, J., Mallard, C, Sirimanne, E., Dragunow, M., Klempt, M., Singh, K., Williams, C., and Nikolics, K. (1992) The role for IGF-I in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182, 593–599.
Bayne, M. L., Applebaum, J., Chicchi, G. G., Hayes, N. S., Green, B. G., and Cascieri, M. A. (1988) Expression, purification and characterization of recombinant human insulin-like growth factor I in yeast. Gene 66, 235–244.
Elliott, S., Fagin, K. D., Nahri, L. O., Miller, J. A., Jones, M., Koski, R., Peters, M., Hsieh, P., Sachdev, R., Rosenfeld, R. D., Rohde, M. F., and Arakawa, T. (1990) Yeast-derived recombinant human insulin-like growth factor I: production, purification, and structural characterization. J. Protein Chem. 9, 95–104.
Meng, H., Burleigh, B. D., and Kelly, G. M. (1988) Reduction studies on bacterial recombinant human somatomedin C/insulin-like growth factor I. J. Chromatogr. 443, 183–192.
Chang, J. Y. and Swartz, J. R. (1993) Single step solubilization and folding of IGF-I aggregates from Escherichia coli, in Protein Folding In Vivo and In Vitro (Cleland, J. L., ed.), ACS Symp. Ser. 526, American Chemical Society, Washington, DC, pp. 178–188.
Scott, R. W., Brierley, R. A., and Howland, D. S. (1996) Secretion sequence for the production of a heterologous protein in yeast. US Patent 5,521,086.
Stroman, D. W., Cregg, J. M., Harpold, M. M., and Sperl, G. T. (1989) Transformation of yeasts of the genus Pichia. US Patent 4,879,23.
Gleeson, M. A. and Howard, B. D. (1994) US Patent 5,324,660.
Jones, E. (1977) Proteinase mutants of Saccharomyces cerevisiae. Genetics 85, 23–33.
Thill, G. P., Davis, G. R., Stillman, C., Holtz, G., Brierley, R. A., Engel, M., Buckholz, R., Kinney, J., Provow, S., Vedvick, T., and Siegel, R. S. (1990) Positive and negative effects of multi-copy integrated expression vectors on protein expression in Pichia pastoris, in Proceedings of 6th International Symposium on Genetics of Industrial Microorganisms, vol. 2 (Heslot, H., Davies, J., Bobichon, L., Durand, G., and Penasse, L., eds.), Societé Française de Microbiologie, Paris, pp. 477–490.
Brierley, R. A., Davis, G. R., and Holz, G. C. (1994) Production of insulin-like growth factor-1 in methylotrophic yeast cells. US Patent 5,234,639.
Holz, G. C. and Brierley, R. A. (1993) Method for the purification of intact, correctly folded insulin-like growth factor-1. US Patent 5,231,178.
Brierley, R. A., Abrams, J. A., Hanson, J. M., and Maslanka, F. C. (1996) IGF-I purification process. International Patent Application, Publ. No. WO 96/32407.
Schagger, H. and von Jagow, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368–379.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Brierley, R.A. (1998). Secretion of Recombinant Human Insulin-Like Growth Factor I (IGF-I). In: Higgins, D.R., Cregg, J.M. (eds) Pichia Protocols. Methods in Molecular Biology, vol 103. Humana, Totowa, NJ. https://doi.org/10.1385/0-89603-421-6:149
Download citation
DOI: https://doi.org/10.1385/0-89603-421-6:149
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-0-89603-421-1
Online ISBN: 978-1-59259-578-5
eBook Packages: Springer Protocols